VRTX Financials

Vertex Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$454.67

Market Cap

$118.09B

P/E Ratio

32.4

EPS

$14.23

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$11.02B

Gross Profit

Operating Income

Net Income

$-535.60M

EPS (Diluted)

$-2.08

Balance Sheet Highlights

Total Assets

$22.53B

Total Liabilities

$6.12B

Shareholders Equity

$16.41B

Cash & Equivalents

$4.57B

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-492.60M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

52.7%

Operating Margin

0.4%

Net Margin

0.3%

ROE

0.2%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is VRTX revenue?

VRTX's most recent quarterly revenue was $11.02B. Annual revenue can be calculated by summing the four most recent quarters.

Is VRTX profitable?

VRTX reported a loss of $535.60M in the most recent quarter. The net profit margin is 0.3%.

What is VRTX market cap?

VRTX has a market capitalization of $118.09B, making it a large-cap stock.

Does VRTX have debt?

View VRTX's balance sheet for debt information.

What is VRTX cash flow?

Cash flow data is available in the full financial statements.